At her 2011 Harvard University Class Day address, Amy Poehler said “You can’t do it alone. As you navigate through…
Read MoreMore Articles
Angelo DiGeorge (April 15, 1921-October 11, 2009) Submitted by Alan Rogol Angelo DiGeorge, a founding member of (Lawson Wilkins) Pediatric Endocrine Society), described a form of an autosomal dominant immunodeficiency…
Read More
Sarah Sparks, MSN, CRNP, FNP-C Sarah Sparks is a board-certified nurse practitioner in the Division of Pediatric Endocrinology and Diabetes at Children’s of Alabama, where she has worked since 2018.…
Read More
Ryan Canter, MD I am a current second year combined adult/pediatric endocrinology fellow at the University of Utah. Originally from the Maryland suburbs of Washington, DC, I attended St. Mary’s…
Read More
The Biological Reality of Sex and Intersex: A Response to the Executive Order, “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government” What is the…
Read More
I am writing today with the sad news that Dr. Frank S. French passed away on February 7th, 2025. Dr. French served as a faculty member and scientist at the…
Read More
Dear PES Members, At each year’s Annual Meeting there is a Presidential Address. Over the years, these talks have showcased incredible and productive careers; meaningful advances in knowledge; journeys taken…
Read More
Marinés Castillo Echevarría, MD My name is Marinés Castillo Echevarría, an Endocrinology Fellow in my final year of training at the University of Alabama at Birmingham, Department of Pediatrics. I…
Read More
Andrezej Viktor “Andrew” Schally, Ph.D. (November 30, 1926 to October 17, 2024) Submitted by Alan Rogol Andrew Schally is a recently deceased Polish-American scientist who shared the 1977 Nobel Prize…
Read More
Katie Flass, PA-C Katie earned her undergraduate degree from Colorado State University in 2005 and a master’s in Physician Assistant Studies from the University of Colorado’s CHA/PA program in 2010.…
Read More
New Drugs and Therapeutics Update CRENESSITY (crinecerfont) capsules and oral solution On December 13, 2024, the FDA approved CRENESSITYTM (crinecerfont) as adjunctive treatment to glucocorticoid replacement to control androgen levels…
Read More